UMIN-CTR Clinical Trial

Recruitment status Open public recruiting
Unique ID issued by UMIN UMIN000026128
Receipt No. R000029643
Official scientific title of the study Association between pupillary autonomic dysfunction and visual hallucination in Parkinson's disease
Date of disclosure of the study information 2017/04/01
Last modified on 2018/08/29 (Ver. 2)

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information
Official scientific title of the study Association between pupillary autonomic dysfunction and visual hallucination in Parkinson's disease
Title of the study (Brief title) Association between pupillary autonomic dysfunction and visual hallucination in Parkinson's disease
Region
Japan

Condition
Condition Parkinson's disease
Classification by specialty
Neurology
Classification by malignancy Others
Genomic information NO

Objectives
Narrative objectives1 To reserch the association between pupillary autonomic dysfunction and visual hallucination in Parkinson's disease
Basic objectives2 Efficacy
Basic objectives -Others
Trial characteristics_1
Trial characteristics_2
Developmental phase

Assessment
Primary outcomes Pupil light reflex evaluation with pupillometry
Key secondary outcomes

Base
Study type Interventional

Study design
Basic design Parallel
Randomization Non-randomized
Randomization unit
Blinding Open -no one is blinded
Control Active
Stratification
Dynamic allocation
Institution consideration
Blocking
Concealment

Intervention
No. of arms 2
Purpose of intervention Prevention
Type of intervention
Medicine
Interventions/Control_1 administe pilocarpine and dipivefrine
Interventions/Control_2 administe pilocarpine and dipivefrine
Interventions/Control_3
Interventions/Control_4
Interventions/Control_5
Interventions/Control_6
Interventions/Control_7
Interventions/Control_8
Interventions/Control_9
Interventions/Control_10

Eligibility
Age-lower limit
40 years-old <=
Age-upper limit
90 years-old >=
Gender Male and Female
Key inclusion criteria Parkinsonism
Normal within brain CT or MRI
Not taking any drugs causing parkinsonism
Antiparkinson drug is efficacious
Key exclusion criteria diabate
peripheral neuropathy
eye disease
Target sample size 60

Research contact person
Name of lead principal investigator Masahisa Katsuno
Organization Nagoya university graduate school of medicine
Division name neurology
Address 65 Tsurumai-cho,Showa-ku,Nagoya
TEL 052-744-2391
Email ka2no@med.nagoya-u.ac.jp

Public contact
Name of contact person Tomohiko Nakamura
Organization Nagoya university graduate school of medicine
Division name inspection unit
Address 65 Tsurumai-cho,Showa-ku,Nagoya
TEL 052-744-2391
Homepage URL
Email tomohiko@med.nagoya-u.ac.jp

Sponsor
Institute Nagoya University
Institute
Department

Funding Source
Organization Ministry of education culture,sports,science and technology-Japan
Organization
Division
Category of Funding Organization Japanese Governmental office
Nationality of Funding Organization

Other related organizations
Co-sponsor
Name of secondary funder(s)

Secondary IDs
Secondary IDs NO
Study ID_1
Org. issuing International ID_1
Study ID_2
Org. issuing International ID_2
IND to MHLW

Institutions
Institutions

Other administrative information
Date of disclosure of the study information
2017 Year 04 Month 01 Day

Progress
Recruitment status Open public recruiting
Date of protocol fixation
2017 Year 01 Month 01 Day
Anticipated trial start date
2017 Year 04 Month 01 Day
Last follow-up date
Date of closure to data entry
Date trial data considered complete
Date analysis concluded

Related information
URL releasing protocol
Publication of results Unpublished
URL releasing results
Results
Other related information

Management information
Registered date
2017 Year 02 Month 14 Day
Last modified on
2018 Year 08 Month 29 Day


Link to view the page
URL(English) https://upload.umin.ac.jp/cgi-open-bin/icdr_e/ctr_view.cgi?recptno=R000029643